Didymin Alleviates Hepatic Fibrosis Through Inhibiting ERK and PI3K/Akt Pathways via Regulation of Raf Kinase Inhibitor Protein
Lin, Xing, Bai, Faicheng, Nie, Jinlan, Lu, Shengjuan, Lu, Chunyuang, Zhu, Xunshuai, Wei, Jinbin, Lu, Zhongpeng, Huang, Quanfang
Published in Cellular physiology and biochemistry (01.01.2016)
Published in Cellular physiology and biochemistry (01.01.2016)
Get full text
Journal Article
Didymin ameliorates hepatic injury through inhibition of MAPK and NF-κB pathways by up-regulating RKIP expression
Huang, Quanfang, Bai, Facheng, Nie, Jinlan, Lu, Shengjuan, Lu, Chunyuang, Zhu, Xunshuai, Zhuo, Lang, Lin, Xing
Published in International immunopharmacology (01.01.2017)
Published in International immunopharmacology (01.01.2017)
Get full text
Journal Article
Didymin induces apoptosis through mitochondrial dysfunction and up-regulation of RKIP in human hepatoma cells
Wei, Jinbin, Huang, Quanfang, Bai, Facheng, Lin, Jun, Nie, Jinlan, Lu, Shengjuan, Lu, Chunyuang, Huang, Renbin, Lu, Zhongpeng, Lin, Xing
Published in Chemico-biological interactions (05.01.2017)
Published in Chemico-biological interactions (05.01.2017)
Get full text
Journal Article
Corrigendum to “Didymin induces apoptosis through mitochondrial dysfunction and up-regulation of RKIP in human hepatoma cells” [Chem. Biol. Interact. 261 (2017) 118-126]
Wei, Jinbin, Huang, Quanfang, Bai, Facheng, Lin, Jun, Nie, Jinlan, Lu, Shengjuan, Lu, Chunyuang, Huang, Renbin, Lu, Zhongpeng, Lin, Xing
Published in Chemico-biological interactions (25.01.2021)
Published in Chemico-biological interactions (25.01.2021)
Get full text
Journal Article